SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. The company offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image process… Read more
SonoScape Medical Corp (300633) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.042x
Based on the latest financial reports, SonoScape Medical Corp (300633) has a cash flow conversion efficiency ratio of -0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-130.62 Million) by net assets (CN¥3.12 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SonoScape Medical Corp - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how SonoScape Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SonoScape Medical Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SonoScape Medical Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hsino Tower Group Co., Ltd.
SHG:601096
|
0.055x |
|
Hangzhou XZB Tech Co Ltd
SHG:603040
|
0.064x |
|
CP Axtra Public Company Limited
BK:CPAXT
|
0.004x |
|
Tongyang Inc
KO:001527
|
-0.001x |
|
Man Wah Holdings Limited
F:AAM
|
0.065x |
|
Zhejiang Guyuelongshan Shaoxing Wine Co Ltd
SHG:600059
|
-0.006x |
|
AEHR TEST SYSTEMS DL-01
F:AYB
|
N/A |
|
Regis Healthcare Ltd
AU:REG
|
-5.831x |
Annual Cash Flow Conversion Efficiency for SonoScape Medical Corp (2012–2024)
The table below shows the annual cash flow conversion efficiency of SonoScape Medical Corp from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.11 Billion | CN¥306.66 Million | 0.099x | -37.15% |
| 2023-12-31 | CN¥3.15 Billion | CN¥493.88 Million | 0.157x | -9.12% |
| 2022-12-31 | CN¥2.74 Billion | CN¥473.26 Million | 0.173x | +34.27% |
| 2021-12-31 | CN¥2.36 Billion | CN¥302.99 Million | 0.129x | -36.18% |
| 2020-12-31 | CN¥1.34 Billion | CN¥271.13 Million | 0.202x | +48.68% |
| 2019-12-31 | CN¥1.40 Billion | CN¥190.39 Million | 0.136x | -23.93% |
| 2018-12-31 | CN¥1.31 Billion | CN¥233.65 Million | 0.178x | +38.62% |
| 2017-12-31 | CN¥1.06 Billion | CN¥136.21 Million | 0.129x | -32.61% |
| 2016-12-31 | CN¥720.11 Million | CN¥137.38 Million | 0.191x | +91.91% |
| 2015-12-31 | CN¥566.21 Million | CN¥56.29 Million | 0.099x | -61.06% |
| 2014-12-31 | CN¥444.81 Million | CN¥113.55 Million | 0.255x | +3.61% |
| 2013-12-31 | CN¥365.08 Million | CN¥89.94 Million | 0.246x | +459.62% |
| 2012-12-31 | CN¥351.82 Million | CN¥15.49 Million | 0.044x | -- |